{"id":76120,"date":"2026-10-08T20:54:41","date_gmt":"2026-10-08T20:54:41","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=76120"},"modified":"2026-10-08T20:54:41","modified_gmt":"2026-10-08T20:54:41","slug":"u-s-analyst-updates-october-8th-2026","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-8th-2026\/","title":{"rendered":"U.S. Analyst Updates: October 8th, 2026"},"content":{"rendered":"

Analyst Ratings (USA)<\/a><\/h2>\n

Today\u2019s U.S. analyst updates suggest a selectively positive outlook, with greater caution on valuations. Technology and AI-related businesses retain bullish support, although semiconductor downgrades and software target cuts show uneven confidence. Healthcare and biotechnology remain mixed, with higher targets for selected drug developers alongside cuts elsewhere. Energy sees substantial target increases, but refinery downgrades indicate that higher valuations do not always mean stronger recommendations. Financials show a balanced mix of\u00a0 ratings, with Industrials, transportation and building materials facing widespread target reductions, while consumer sectors remain divided between cautious apparel, beverage and restaurant forecasts and more positive travel and leisure recommendations.<\/p>\n

Updates (291)<\/h3>\n

AbbVie (ABBV)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and raised its price target to US$290.00 from US$285.00.<\/p>\n

ACADIA Pharmaceuticals (ACAD)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and lowered its price target to US$36.00 from US$37.00.<\/p>\n

Acuity (AYI)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and lowered its price target to US$415.00 from US$440.00.<\/p>\n

AECOM (ACM)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to US$103.00 from US$106.00.<\/p>\n

AGCO (AGCO)<\/strong> \u2014 D.A. Davidson reiterated its Buy rating with a US$151.00 price target.<\/p>\n

AGCO (AGCO)<\/strong> \u2014 Oppenheimer reiterated its Outperform rating.<\/p>\n

Agnico Eagle Mines (AEM)<\/strong> \u2014 UBS maintained its Neutral rating and raised its price target to US$190.00 from US$170.00.<\/p>\n

Alibaba Group (BABA)<\/strong> \u2014 Citigroup reiterated its Buy rating.<\/p>\n

Alibaba Group (BABA)<\/strong> \u2014 Jefferies reiterated its Buy rating with a US$192.00 price target.<\/p>\n

Alibaba Group (BABA)<\/strong> \u2014 Piper Sandler downgraded the stock to Hold.<\/p>\n

Allison Transmission (ALSN)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to US$120.00 from US$137.00.<\/p>\n

Alnylam Pharmaceuticals (ALNY)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and lowered its price target to US$345.00 from US$350.00.<\/p>\n

Alpha Metallurgical Resources (AMR)<\/strong> \u2014 UBS maintained its Neutral rating and raised its price target to US$180.00 from US$160.00.<\/p>\n

Alphabet (GOOGL)<\/strong> \u2014 Needham reiterated its Buy rating with a US$450.00 price target.<\/p>\n

Alphabet (GOOG)<\/strong> \u2014 Stifel set a US$485.00 price target.<\/p>\n

Alphabet (GOOG)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to US$485.00 from US$475.00.<\/p>\n

Amgen (AMGN)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and raised its price target to US$430.00 from US$400.00.<\/p>\n

Amphenol (APH)<\/strong> \u2014 Citigroup reiterated its Buy rating.<\/p>\n

Antero Resources (AR)<\/strong> \u2014 Mizuho maintained its Outperform rating and lowered its price target to US$51.00 from US$57.00.<\/p>\n

Applied Digital (APLD)<\/strong> \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n

Applied Digital (APLD)<\/strong> \u2014 Needham maintained its Buy rating and lowered its price target to US$70.00 from US$83.00.<\/p>\n

Applied Digital (APLD)<\/strong> \u2014 UBS reiterated its Buy rating.<\/p>\n

Applied Digital (APLD)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and raised its price target to US$55.00 from US$50.00.<\/p>\n

AppLovin (APP)<\/strong> \u2014 Jefferies reiterated its Buy rating with a US$375.00 price target.<\/p>\n

ArcBest (ARCB)<\/strong> \u2014 Stifel maintained its Buy rating and lowered its price target to US$168.00 from US$185.00.<\/p>\n

Arcutis Biotherapeutics (ARQT)<\/strong> \u2014 Jefferies reiterated its Buy rating with a US$39.00 price target.<\/p>\n

Arista Networks (ANET)<\/strong> \u2014 Citigroup reiterated its Buy rating.<\/p>\n

ArriVent BioPharma (AVBP)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating and lowered its price target to US$27.00 from US$47.00.<\/p>\n

ATI (ATI)<\/strong> \u2014 KeyBanc Capital Markets maintained its Overweight rating and lowered its price target to US$228.00 from US$258.00.<\/p>\n

Aurora Innovation (AUR)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and raised its price target to US$16.00 from US$15.00.<\/p>\n

Axsome Therapeutics (AXSM)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and lowered its price target to US$295.00 from US$297.00.<\/p>\n

Banco Bradesco (BBD)<\/strong> \u2014 HSBC Securities downgraded its rating to Hold from Buy with a US$3.90 price target.<\/p>\n

Bank of America (BAC)<\/strong> \u2014 TD Cowen resumed coverage with a Hold rating and a US$60.00 price target.<\/p>\n

Bank of New York Mellon (BNY)<\/strong> \u2014 TD Cowen resumed coverage with a Hold rating and a US$160.00 price target.<\/p>\n

Bausch Health Cos (BHC)<\/strong> \u2014 RBC Capital Markets reiterated its Sector Perform rating with a US$9.00 price target.<\/p>\n

BCE (BCE)<\/strong> \u2014 CIBC reiterated its Outperform rating.<\/p>\n

BeOne Medicines (ONC)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and raised its price target to US$459.00 from US$450.00.<\/p>\n

Biogen (BIIB)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and lowered its price target to US$256.00 from US$260.00.<\/p>\n

Biohaven (BHVN)<\/strong> \u2014 Raymond James reiterated its Strong Buy rating.<\/p>\n

BioNTech (BNTX)<\/strong> \u2014 Argus initiated coverage with a Hold rating.<\/p>\n

BJ’s Wholesale Club (BJ)<\/strong> \u2014 D.A. Davidson set a US$108.00 price target.<\/p>\n

Black Hills (BKH)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and raised its price target to US$86.00 from US$83.00.<\/p>\n

BlackRock (BLK)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to US$1,230.00 from US$1,245.00.<\/p>\n

Blackstone (BX)<\/strong> \u2014 Barclays maintained its Equal Weight rating and lowered its price target to US$124.00 from US$128.00.<\/p>\n

Booz Allen Hamilton (BAH)<\/strong> \u2014 Truist Securities upgraded its rating to Buy from Hold and raised its price target to US$85.00 from US$70.00.<\/p>\n

Bristol Myers Squibb (BMY)<\/strong> \u2014 Cantor Fitzgerald maintained its Neutral rating and lowered its price target to US$53.00 from US$59.00.<\/p>\n

Builders FirstSource (BLDR)<\/strong> \u2014 Citigroup reiterated its Market Perform rating.<\/p>\n

Builders FirstSource (BLDR)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to US$70.00 from US$90.00.<\/p>\n

C.H. Robinson Worldwide (CHRW)<\/strong> \u2014 Stifel set a US$209.00 price target.<\/p>\n

Camping World (CWH)<\/strong> \u2014 KeyBanc Capital Markets maintained its Overweight rating and lowered its price target to US$8.00 from US$9.00.<\/p>\n

Capricor Therapeutics (CAPR)<\/strong> \u2014 Oppenheimer reiterated its Outperform rating.<\/p>\n

Caribou Biosciences (CRBU)<\/strong> \u2014 H.C. Wainwright downgraded its rating to Neutral from Buy.<\/p>\n

Carlyle Group (CG)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to US$53.00 from US$64.00.<\/p>\n

Carpenter Technology (CRS)<\/strong> \u2014 KeyBanc Capital Markets maintained its Overweight rating and lowered its price target to US$465.00 from US$608.00.<\/p>\n

CAVA Group (CAVA)<\/strong> \u2014 Melius upgraded its rating to Buy from Hold with a US$95.00 price target.<\/p>\n

CenterPoint Energy (CNP)<\/strong> \u2014 Citigroup reiterated its Neutral rating.<\/p>\n

Centrus Energy (LEU)<\/strong> \u2014 Guggenheim initiated coverage with a Buy rating and a US$167.00 price target.<\/p>\n

Century Aluminum (CENX)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to US$55.00 from US$60.00.<\/p>\n

Chevron (CVX)<\/strong> \u2014 UBS maintained its Buy rating and raised its price target to US$235.00 from US$220.00.<\/p>\n

Chime Financial (CHYM)<\/strong> \u2014 Deutsche Bank upgraded its rating to Buy from Hold and raised its price target to US$35.00 from US$30.00.<\/p>\n

Chime Financial (CHYM)<\/strong> \u2014 Raymond James set a US$35.00 price target.<\/p>\n

Citigroup (C)<\/strong> \u2014 TD Cowen resumed coverage with a Buy rating and a US$150.00 price target.<\/p>\n

Citizens Financial Group (CFG)<\/strong> \u2014 TD Cowen resumed coverage with a Buy rating and a US$75.00 price target.<\/p>\n

Clean Harbors (CLH)<\/strong> \u2014 Barclays maintained its Equal Weight rating and raised its price target to US$335.00 from US$325.00.<\/p>\n

Connect Biopharma (CNTB)<\/strong> \u2014 H.C. Wainwright reiterated its Buy rating.<\/p>\n

Constellation Brands (STZ)<\/strong> \u2014 BMO Capital Markets reiterated its Outperform rating.<\/p>\n

Constellation Brands (STZ)<\/strong> \u2014 Deutsche Bank maintained its Hold rating and lowered its price target to US$127.00 from US$136.00.<\/p>\n

Constellation Brands (STZ)<\/strong> \u2014 HSBC Securities downgraded its rating to Hold from Buy with a US$135.00 price target.<\/p>\n

Constellation Brands (STZ)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$145.00 from US$158.00.<\/p>\n

Constellation Brands (STZ)<\/strong> \u2014 Needham maintained its Buy rating and lowered its price target to US$150.00 from US$185.00.<\/p>\n

Constellation Brands (STZ)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to US$125.00 from US$161.00.<\/p>\n

Constellation Brands (STZ)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and lowered its price target to US$182.00 from US$185.00.<\/p>\n

Constellation Brands (STZ)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to US$144.00 from US$145.00.<\/p>\n

Constellium (CSTM)<\/strong> \u2014 Deutsche Bank maintained its Buy rating and lowered its price target to US$36.00 from US$39.00.<\/p>\n

Constellium (CSTM)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to US$32.00 from US$34.00.<\/p>\n

Corteva (CTVA)<\/strong> \u2014 Goldman Sachs reiterated its Buy rating with a US$20.00 price target.<\/p>\n

Cummins (CMI)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to US$760.00 from US$874.00.<\/p>\n

CVR Energy (CVI)<\/strong> \u2014 Mizuho maintained its Underperform rating and raised its price target to US$52.00 from US$29.00.<\/p>\n

Cytokinetics (CYTK)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and raised its price target to US$113.00 from US$112.00.<\/p>\n

Delek US (DK)<\/strong> \u2014 Mizuho downgraded its rating to Neutral from Outperform and raised its price target to US$83.00 from US$66.00.<\/p>\n

The Descartes Systems Group (DSGX)<\/strong> \u2014 Loop Capital reiterated its Buy rating with a US$96.00 price target.<\/p>\n

DraftKings (DKNG)<\/strong> \u2014 Susquehanna maintained its Positive rating and lowered its price target to US$27.00 from US$33.00.<\/p>\n

Dynatrace (DT)<\/strong> \u2014 BNP Paribas Exane upgraded its rating to Outperform from Neutral with a US$75.00 price target.<\/p>\n

Eagle Materials (EXP)<\/strong> \u2014 Truist Securities maintained its Hold rating and lowered its price target to US$165.00 from US$210.00.<\/p>\n

Editas Medicine (EDIT)<\/strong> \u2014 Wells Fargo upgraded its rating to Overweight from Equal Weight and raised its price target to US$6.00 from US$4.00.<\/p>\n

Edwards Lifesciences (EW)<\/strong> \u2014 UBS reiterated its Buy rating.<\/p>\n

Eli Lilly and Company (LLY)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and raised its price target to US$1,440.00 from US$1,410.00.<\/p>\n

Elmet Group (ELMT)<\/strong> \u2014 Needham maintained its Buy rating and raised its price target to US$28.00 from US$25.00.<\/p>\n

Enliven Therapeutics (ELVN)<\/strong> \u2014 Guggenheim reiterated its Buy rating.<\/p>\n

Entegris (ENTG)<\/strong> \u2014 Stifel initiated coverage with a Buy rating and a US$200.00 price target.<\/p>\n

Eupraxia Pharmaceuticals (EPRX)<\/strong> \u2014 Cantor Fitzgerald reiterated its Overweight rating.<\/p>\n

Everpure (P)<\/strong> \u2014 Needham maintained its Buy rating and raised its price target to US$185.00 from US$150.00.<\/p>\n

Exelixis (EXEL)<\/strong> \u2014 RBC Capital Markets maintained its Sector Perform rating and lowered its price target to US$45.00 from US$46.00.<\/p>\n

FedEx Freight (FDXF)<\/strong> \u2014 Stifel maintained its Hold rating and lowered its price target to US$129.00 from US$160.00.<\/p>\n

Fifth Third Bancorp (FITB)<\/strong> \u2014 TD Cowen resumed coverage with a Buy rating and a US$60.00 price target.<\/p>\n

First Solar (FSLR)<\/strong> \u2014 Goldman Sachs maintained its Buy rating and lowered its price target to US$272.00 from US$310.00.<\/p>\n

Fiserv (FISV)<\/strong> \u2014 Oppenheimer downgraded its rating to Perform from Outperform.<\/p>\n

Flutter Entertainment (FLUT)<\/strong> \u2014 Susquehanna maintained its Positive rating and lowered its price target to US$100.00 from US$115.00.<\/p>\n

Flutter Entertainment (FLUT)<\/strong> \u2014 Wedbush maintained its Outperform rating and lowered its price target to US$110.00 from US$126.00.<\/p>\n

Forward Air (FWRD)<\/strong> \u2014 Stifel maintained its Buy rating and lowered its price target to US$24.00 from US$27.00.<\/p>\n

Freeport-McMoRan (FCX)<\/strong> \u2014 UBS maintained its Buy rating and raised its price target to US$88.00 from US$77.00.<\/p>\n

FrontView REIT (FVR)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to US$20.00 from US$24.00.<\/p>\n

Garrett Motion (GTX)<\/strong> \u2014 BWS Financial reiterated its Buy rating with a US$42.00 price target.<\/p>\n

Gartner (IT)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$182.00 from US$177.00.<\/p>\n

GATX (GATX)<\/strong> \u2014 Citigroup reiterated its Buy rating.<\/p>\n

Generac (GNRC)<\/strong> \u2014 KeyBanc Capital Markets upgraded its rating to Overweight from Sector Weight with a US$280.00 price target.<\/p>\n

Generac (GNRC)<\/strong> \u2014 Piper Sandler initiated coverage with a Overweight rating and a US$303.00 price target.<\/p>\n

Genius Sports (GENI)<\/strong> \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n

Gilead Sciences (GILD)<\/strong> \u2014 Cantor Fitzgerald reiterated its Overweight rating with a US$155.00 price target.<\/p>\n

Gilead Sciences (GILD)<\/strong> \u2014 RBC Capital Markets maintained its Sector Perform rating and raised its price target to US$126.00 from US$123.00.<\/p>\n

Global Payments (GPN)<\/strong> \u2014 Oppenheimer upgraded its rating to Outperform from Market Perform with a US$115.00 price target.<\/p>\n

Gold Royalty (GROY)<\/strong> \u2014 TD Securities initiated coverage with a Buy rating and a US$4.00 price target.<\/p>\n

The Goldman Sachs Group (GS)<\/strong> \u2014 Loop Capital set a US$1,050.00 price target.<\/p>\n

The Goldman Sachs Group (GS)<\/strong> \u2014 TD Cowen initiated coverage with a Buy rating and a US$1,050.00 price target.<\/p>\n

Graham (GHM)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and lowered its price target to US$115.00 from US$130.00.<\/p>\n

Haemonetics (HAE)<\/strong> \u2014 BTIG Research maintained its Buy rating and raised its price target to US$130.00 from US$110.00.<\/p>\n

Hasbro (HAS)<\/strong> \u2014 UBS reiterated its Buy rating.<\/p>\n

Healthcare Services Group (HCSG)<\/strong> \u2014 Baird maintained its Neutral rating and lowered its price target to US$24.00 from US$26.00.<\/p>\n

Herc (HRI)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to US$176.00 from US$218.00.<\/p>\n

HF Sinclair (DINO)<\/strong> \u2014 Mizuho maintained its Neutral rating and raised its price target to US$119.00 from US$85.00.<\/p>\n

Hilton Grand Vacations (HGV)<\/strong> \u2014 JPMorgan initiated coverage with a Neutral rating and a US$39.00 price target.<\/p>\n

Houlihan Lokey (HLI)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$165.00 from US$177.00.<\/p>\n

HubSpot (HUBS)<\/strong> \u2014 JPMorgan downgraded its rating to Neutral from Overweight with a US$240.00 price target.<\/p>\n

Huntington Bancshares (HBAN)<\/strong> \u2014 TD Cowen resumed coverage with a Buy rating and a US$18.00 price target.<\/p>\n

Hut 8 (HUT)<\/strong> \u2014 UBS reiterated its Buy rating.<\/p>\n

Hyatt Hotels (H)<\/strong> \u2014 Mizuho maintained its Outperform rating and raised its price target to US$222.00 from US$221.00.<\/p>\n

IMAX (IMAX)<\/strong> \u2014 B. Riley Securities maintained its Buy rating and raised its price target to US$64.00 from US$61.00.<\/p>\n

Incyte (INCY)<\/strong> \u2014 RBC Capital Markets maintained its Sector Perform rating and raised its price target to US$114.00 from US$109.00.<\/p>\n

Insmed (INSM)<\/strong> \u2014 UBS reiterated its Buy rating.<\/p>\n

Installed Building Products (IBP)<\/strong> \u2014 Truist Securities maintained its Hold rating and lowered its price target to US$160.00 from US$200.00.<\/p>\n

Iovance Biotherapeutics (IOVA)<\/strong> \u2014 Baird maintained its Neutral rating and raised its price target to US$11.00 from US$6.00.<\/p>\n

Itau Unibanco (ITUB)<\/strong> \u2014 HSBC Securities downgraded its rating to Hold from Buy with a US$9.10 price target.<\/p>\n

J.B. Hunt Transport Services (JBHT)<\/strong> \u2014 Stifel maintained its Hold rating and lowered its price target to US$289.00 from US$292.00.<\/p>\n

Jabil (JBL)<\/strong> \u2014 UBS reiterated its Buy rating.<\/p>\n

Jackson Financial (JXN)<\/strong> \u2014 Barclays set a US$151.00 price target.<\/p>\n

Jazz Pharmaceuticals (JAZZ)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and lowered its price target to US$296.00 from US$299.00.<\/p>\n

Johnson Controls International (JCI)<\/strong> \u2014 Bank of America maintained its Buy rating and raised its price target to US$175.00 from US$152.00.<\/p>\n

Johnson Controls International (JCI)<\/strong> \u2014 Citigroup reiterated its Buy rating.<\/p>\n

JPMorgan Chase & Co. (JPM)<\/strong> \u2014 TD Cowen resumed coverage with a Hold rating and a US$370.00 price target.<\/p>\n

Kaiser Aluminum (KALU)<\/strong> \u2014 KeyBanc Capital Markets maintained its Overweight rating and lowered its price target to US$181.00 from US$183.00.<\/p>\n

KeyCorp (KEY)<\/strong> \u2014 TD Cowen resumed coverage with a Buy rating and a US$23.00 price target.<\/p>\n

Kinross Gold (KGC)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to US$28.00 from US$30.00.<\/p>\n

KKR & Co. Inc. (KKR)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to US$130.00 from US$135.00.<\/p>\n

Knight-Swift Transportation (KNX)<\/strong> \u2014 Stifel maintained its Buy rating and raised its price target to US$90.00 from US$88.00.<\/p>\n

Kodiak Gas Services (KGS)<\/strong> \u2014 Jefferies reiterated its Buy rating with a US$65.00 price target.<\/p>\n

Kratos Defense & Security Solutions (KTOS)<\/strong> \u2014 BNP Paribas Exane upgraded its rating to Outperform from Neutral.<\/p>\n

Lamb Weston (LW)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to US$58.00 from US$56.00.<\/p>\n

Lamb Weston (LW)<\/strong> \u2014 Stephens maintained its Equal Weight rating and raised its price target to US$55.00 from US$50.00.<\/p>\n

Latham Group (SWIM)<\/strong> \u2014 William Blair downgraded its rating to Market Perform from Outperform.<\/p>\n

Lazard (LAZ)<\/strong> \u2014 Morgan Stanley maintained its Underweight rating and lowered its price target to US$41.00 from US$44.00.<\/p>\n

LCNB (LCNB)<\/strong> \u2014 Piper Sandler initiated coverage with a Neutral rating and a US$20.00 price target.<\/p>\n

Legend Biotech (LEGN)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and lowered its price target to US$56.00 from US$58.00.<\/p>\n

Leidos (LDOS)<\/strong> \u2014 JPMorgan downgraded its rating to Neutral from Overweight and lowered its price target to US$142.00 from US$160.00.<\/p>\n

Levi Strauss & Co. (LEVI)<\/strong> \u2014 Bank of America maintained its Buy rating and lowered its price target to US$25.00 from US$27.00.<\/p>\n

Levi Strauss & Co. (LEVI)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to US$26.00 from US$27.00.<\/p>\n

Levi Strauss & Co. (LEVI)<\/strong> \u2014 BTIG Research reiterated its Buy rating with a US$27.00 price target.<\/p>\n

Levi Strauss & Co. (LEVI)<\/strong> \u2014 Needham reiterated its Buy rating with a US$28.00 price target.<\/p>\n

Levi Strauss & Co. (LEVI)<\/strong> \u2014 Raymond James maintained its Outperform rating and lowered its price target to US$22.00 from US$24.00.<\/p>\n

Levi Strauss & Co. (LEVI)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to US$20.00 from US$25.00.<\/p>\n

LGN (LGN)<\/strong> \u2014 Stifel maintained its Buy rating and lowered its price target to US$82.00 from US$101.00.<\/p>\n

Limbach (LMB)<\/strong> \u2014 Stifel maintained its Buy rating and lowered its price target to US$75.00 from US$86.00.<\/p>\n

Lincoln International (LCLN)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$27.00 from US$28.00.<\/p>\n

Lindblad Expeditions (LIND)<\/strong> \u2014 Jefferies reiterated its Hold rating with a US$32.00 price target.<\/p>\n

Linde (LIN)<\/strong> \u2014 BMO Capital Markets reiterated its Outperform rating.<\/p>\n

M\/I Homes (MHO)<\/strong> \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n

M\/I Homes (MHO)<\/strong> \u2014 Jefferies set a US$165.00 price target.<\/p>\n

M&T Bank (MTB)<\/strong> \u2014 TD Cowen resumed coverage with a Hold rating and a US$245.00 price target.<\/p>\n

Magna International (MGA)<\/strong> \u2014 TD Securities maintained its Buy rating and lowered its price target to US$77.00 from US$80.00.<\/p>\n

Marathon Petroleum (MPC)<\/strong> \u2014 Mizuho maintained its Neutral rating and raised its price target to US$457.00 from US$304.00.<\/p>\n

Marriott Vacations Worldwide (VAC)<\/strong> \u2014 JPMorgan initiated coverage with a Overweight rating and a US$125.00 price target.<\/p>\n

Martin Marietta Materials (MLM)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to US$662.00 from US$715.00.<\/p>\n

MasTec (MTZ)<\/strong> \u2014 Stifel maintained its Buy rating and lowered its price target to US$305.00 from US$376.00.<\/p>\n

McDonald’s (MCD)<\/strong> \u2014 Bernstein maintained its Market Perform rating and lowered its price target to US$250.00 from US$295.00.<\/p>\n

Merck & Co., Inc. (MRK)<\/strong> \u2014 Cantor Fitzgerald maintained its Neutral rating and raised its price target to US$145.00 from US$120.00.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 TD Cowen reiterated its Buy rating with a US$865.00 price target.<\/p>\n

MGM Resorts International (MGM)<\/strong> \u2014 Susquehanna maintained its Positive rating and lowered its price target to US$41.00 from US$46.00.<\/p>\n

MiniMed Group (MMED)<\/strong> \u2014 Mizuho maintained its Outperform rating and raised its price target to US$28.00 from US$26.00.<\/p>\n

Mirum Pharmaceuticals (MIRM)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and raised its price target to US$155.00 from US$135.00.<\/p>\n

Moelis & Company (MC)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$77.00 from US$85.00.<\/p>\n

MongoDB (MDB)<\/strong> \u2014 Scotiabank maintained its Sector Outperform rating and raised its price target to US$450.00 from US$440.00.<\/p>\n

Morgan Stanley (MS)<\/strong> \u2014 Erste Group downgraded its rating to Hold from Buy.<\/p>\n

Morgan Stanley (MS)<\/strong> \u2014 TD Cowen initiated coverage with a Hold rating and a US$210.00 price target.<\/p>\n

MYR Group (MYRG)<\/strong> \u2014 Stifel maintained its Buy rating and lowered its price target to US$393.00 from US$445.00.<\/p>\n

Nasdaq (NDAQ)<\/strong> \u2014 Raymond James reiterated its Outperform rating.<\/p>\n

Nayax Ltd. (NYAX)<\/strong> \u2014 Jefferies resumed coverage with a Buy rating and a US$68.30 price target.<\/p>\n

Nebius Group (NBIS)<\/strong> \u2014 Rosenblatt initiated coverage with a Buy rating and a US$304.00 price target.<\/p>\n

Netflix (NFLX)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$80.00 from US$83.00.<\/p>\n

Neurogene (NGNE)<\/strong> \u2014 JPMorgan initiated coverage with a Overweight rating and a US$60.00 price target.<\/p>\n

New Era Energy & Digital (NUAI)<\/strong> \u2014 Roth Capital initiated coverage with a Buy rating and a US$10.00 price target.<\/p>\n

NextEra Energy (NEE)<\/strong> \u2014 Jefferies reiterated its Hold rating.<\/p>\n

Nomad Foods (NOMD)<\/strong> \u2014 BTIG Research reiterated its Buy rating with a US$15.00 price target.<\/p>\n

Northern Trust (NTRS)<\/strong> \u2014 TD Cowen resumed coverage with a Hold rating and a US$175.00 price target.<\/p>\n

Nova (NVMI)<\/strong> \u2014 Citigroup downgraded its rating to Neutral from Buy with a US$415.00 price target.<\/p>\n

NXP Semi (NXPI)<\/strong> \u2014 Citigroup downgraded its rating to Neutral from Buy with a US$260.00 price target.<\/p>\n

Old Dominion Freight Line (ODFL)<\/strong> \u2014 Stifel maintained its Buy rating and lowered its price target to US$230.00 from US$263.00.<\/p>\n

ONE Gas (OGS)<\/strong> \u2014 Jefferies downgraded its rating to Hold from Buy with a US$80.00 price target.<\/p>\n

OSI Systems (OSIS)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and lowered its price target to US$265.00 from US$300.00.<\/p>\n

Owens Corning (OC)<\/strong> \u2014 Truist Securities maintained its Hold rating and lowered its price target to US$115.00 from US$140.00.<\/p>\n

PACCAR (PCAR)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to US$122.00 from US$157.00.<\/p>\n

Pacira BioSciences (PCRX)<\/strong> \u2014 Needham downgraded its rating to Hold from Buy.<\/p>\n

Palantir Technologies (PLTR)<\/strong> \u2014 Goldman Sachs upgraded its rating to Buy from Neutral with a US$230.00 price target.<\/p>\n

Palantir Technologies (PLTR)<\/strong> \u2014 Raymond James upgraded its rating to Outperform from Market Perform.<\/p>\n

Par Pacific (PARR)<\/strong> \u2014 Mizuho downgraded its rating to Neutral from Outperform with a US$91.00 price target.<\/p>\n

Patrick Industries (PATK)<\/strong> \u2014 KeyBanc Capital Markets maintained its Overweight rating and lowered its price target to US$100.00 from US$115.00.<\/p>\n

PBF Energy (PBF)<\/strong> \u2014 Mizuho maintained its Neutral rating and raised its price target to US$89.00 from US$65.00.<\/p>\n

PepsiCo (PEP)<\/strong> \u2014 Jefferies reiterated its Hold rating.<\/p>\n

Pfizer (PFE)<\/strong> \u2014 Cantor Fitzgerald maintained its Neutral rating and raised its price target to US$28.00 from US$27.00.<\/p>\n

Phillips 66 (PSX)<\/strong> \u2014 Mizuho downgraded its rating to Neutral from Outperform and raised its price target to US$300.00 from US$220.00.<\/p>\n

Pinnacle West Capital (PNW)<\/strong> \u2014 Citigroup reiterated its Neutral rating.<\/p>\n

The PNC Financial Services Group (PNC)<\/strong> \u2014 TD Cowen resumed coverage with a Hold rating and a US$245.00 price target.<\/p>\n

Presidio Production (FTW)<\/strong> \u2014 Stephens initiated coverage with a Overweight rating and a US$15.00 price target.<\/p>\n

Primoris Services (PRIM)<\/strong> \u2014 Jefferies reiterated its Buy rating with a US$99.00 price target.<\/p>\n

Proficient Auto Logistics (PAL)<\/strong> \u2014 Stifel maintained its Buy rating and lowered its price target to US$10.00 from US$12.00.<\/p>\n

PROG (PRG)<\/strong> \u2014 Loop Capital upgraded its rating to Buy from Hold with a US$45.00 price target.<\/p>\n

PulteGroup (PHM)<\/strong> \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n

PulteGroup (PHM)<\/strong> \u2014 Piper Sandler downgraded the stock to Hold with a US$145.00 price target.<\/p>\n

QXO (QXO)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to US$15.00 from US$26.00.<\/p>\n

Regal Rexnord (RRX)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and lowered its price target to US$200.00 from US$245.00.<\/p>\n

Regeneron Pharmaceuticals (REGN)<\/strong> \u2014 RBC Capital Markets maintained its Sector Perform rating and raised its price target to US$810.00 from US$737.00.<\/p>\n

Regions Financial (RF)<\/strong> \u2014 TD Cowen resumed coverage with a Hold rating and a US$30.00 price target.<\/p>\n

Reinsurance Group of America (RGA)<\/strong> \u2014 Barclays set a US$292.00 price target.<\/p>\n

Republic Services (RSG)<\/strong> \u2014 CIBC reiterated its Outperform rating with a US$240.00 price target.<\/p>\n

Revolution Medicines (RVMD)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and raised its price target to US$259.00 from US$251.00.<\/p>\n

Rhythm Pharmaceuticals (RYTM)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and raised its price target to US$159.00 from US$155.00.<\/p>\n

Rocket Pharmaceuticals (RCKT)<\/strong> \u2014 Goldman Sachs upgraded its rating to Neutral from Sell and raised its price target to US$4.00 from US$3.00.<\/p>\n

Royal Caribbean Cruises (RCL)<\/strong> \u2014 Jefferies upgraded its rating to Buy from Hold and raised its price target to US$330.00 from US$305.00.<\/p>\n

RPM International (RPM)<\/strong> \u2014 Deutsche Bank maintained its Buy rating and lowered its price target to US$115.00 from US$126.00.<\/p>\n

Ryder System (R)<\/strong> \u2014 Citigroup upgraded its rating to Buy from Neutral with a US$285.00 price target.<\/p>\n

Ryder System (R)<\/strong> \u2014 Janney Montgomery Scott set a US$285.00 price target.<\/p>\n

Saia (SAIA)<\/strong> \u2014 Stifel maintained its Buy rating and lowered its price target to US$423.00 from US$438.00.<\/p>\n

SailPoint (SAIL)<\/strong> \u2014 Baird maintained its Outperform rating and raised its price target to US$25.00 from US$22.00.<\/p>\n

SAP (SAP)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and raised its price target to US$235.00 from US$177.00.<\/p>\n

Saratoga Investment (SAR)<\/strong> \u2014 B. Riley Securities maintained its Neutral rating and lowered its price target to US$20.00 from US$22.00.<\/p>\n

Saratoga Investment (SAR)<\/strong> \u2014 Compass Point reiterated its Neutral rating with a US$18.00 price target.<\/p>\n

Sarepta Therapeutics (SRPT)<\/strong> \u2014 RBC Capital Markets maintained its Sector Perform rating and lowered its price target to US$17.00 from US$19.00.<\/p>\n

Satellos Bioscience (MSLE)<\/strong> \u2014 Craig Hallum initiated coverage with a Buy rating and a US$24.00 price target.<\/p>\n

Scholar Rock (SRRK)<\/strong> \u2014 Raymond James reiterated its Strong Buy rating.<\/p>\n

Seaport Therapeutics (SPTX)<\/strong> \u2014 H.C. Wainwright reiterated its Buy rating with a US$50.00 price target.<\/p>\n

Seaport Therapeutics (SPTX)<\/strong> \u2014 UBS reiterated its Buy rating.<\/p>\n

Sequans Communications (SQNS)<\/strong> \u2014 Roth Capital reiterated its Buy rating with a US$15.00 price target.<\/p>\n

ServiceTitan (TTAN)<\/strong> \u2014 KeyBanc Capital Markets reiterated its Overweight rating.<\/p>\n

Shoals Technologies Group (SHLS)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to US$11.00 from US$10.00.<\/p>\n

SiteOne Landscape Supply (SITE)<\/strong> \u2014 Deutsche Bank downgraded its rating to Hold from Buy and lowered its price target to US$91.00 from US$127.00.<\/p>\n

Solventum (SOLV)<\/strong> \u2014 Benchmark reiterated its Buy rating.<\/p>\n

Solventum (SOLV)<\/strong> \u2014 Jefferies reiterated its Buy rating.<\/p>\n

Southern Copper (SCCO)<\/strong> \u2014 UBS maintained its Sell rating and raised its price target to US$180.00 from US$160.00.<\/p>\n

SpaceX (SPCX)<\/strong> \u2014 Erste Group initiated coverage with a Hold rating.<\/p>\n

Spotify Technology (SPOT)<\/strong> \u2014 Piper Sandler initiated coverage with a Neutral rating and a US$540.00 price target.<\/p>\n

Starbucks (SBUX)<\/strong> \u2014 UBS maintained its Neutral rating and lowered its price target to US$105.00 from US$112.00.<\/p>\n

State Street (STT)<\/strong> \u2014 TD Cowen resumed coverage with a Buy rating and a US$205.00 price target.<\/p>\n

Sterling Infrastructure (STRL)<\/strong> \u2014 Stifel maintained its Buy rating and lowered its price target to US$742.00 from US$804.00.<\/p>\n

Sunrun (RUN)<\/strong> \u2014 Goldman Sachs maintained its Buy rating and lowered its price target to US$11.00 from US$13.00.<\/p>\n

Super Micro Computer (SMCI)<\/strong> \u2014 Citigroup reiterated its Neutral rating.<\/p>\n

Targa Resources (TRGP)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to US$294.00 from US$284.00.<\/p>\n

TELUS (TU)<\/strong> \u2014 CIBC reiterated its Neutral rating.<\/p>\n

TFI International (TFII)<\/strong> \u2014 Stifel maintained its Hold rating and lowered its price target to US$132.00 from US$160.00.<\/p>\n

Thor Industries (THO)<\/strong> \u2014 Truist Securities maintained its Hold rating and raised its price target to US$87.00 from US$80.00.<\/p>\n

TOYO (TOYO)<\/strong> \u2014 H.C. Wainwright reiterated its Buy rating with a US$18.00 price target.<\/p>\n

TPG (TPG)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to US$60.00 from US$64.00.<\/p>\n

Tractor Supply (TSCO)<\/strong> \u2014 D.A. Davidson set a US$36.00 price target.<\/p>\n

Travel + Leisure (TNL)<\/strong> \u2014 JPMorgan initiated coverage with a Neutral rating and a US$70.00 price target.<\/p>\n

Trex (TREX)<\/strong> \u2014 Deutsche Bank upgraded its rating to Buy from Hold and raised its price target to US$57.00 from US$53.00.<\/p>\n

Truist Financial (TFC)<\/strong> \u2014 TD Cowen resumed coverage with a Hold rating and a US$52.00 price target.<\/p>\n

Truist Financial (TFC)<\/strong> \u2014 Wells Fargo set a US$52.00 price target.<\/p>\n

Twist Bioscience (TWST)<\/strong> \u2014 Jefferies initiated coverage with a Hold rating and a US$150.00 price target.<\/p>\n

TXO Energy Partners (TXO)<\/strong> \u2014 Stephens initiated coverage with a Overweight rating and a US$22.00 price target.<\/p>\n

Tyler Technologies (TYL)<\/strong> \u2014 Goldman Sachs downgraded its rating to Neutral from Buy and lowered its price target to US$345.00 from US$395.00.<\/p>\n

U.S. Bancorp (USB)<\/strong> \u2014 TD Cowen resumed coverage with a Buy rating and a US$70.00 price target.<\/p>\n

United Therapeutics (UTHR)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and raised its price target to US$708.00 from US$677.00.<\/p>\n

Unity Software (U)<\/strong> \u2014 Oppenheimer reiterated its Outperform rating.<\/p>\n

Unity Software (U)<\/strong> \u2014 Raymond James upgraded its rating to Outperform from Market Perform with a US$54.00 price target.<\/p>\n

Universal Display (OLED)<\/strong> \u2014 Citigroup downgraded its rating to Sell from Neutral with a US$71.00 price target.<\/p>\n

Valero Energy (VLO)<\/strong> \u2014 Mizuho maintained its Neutral rating and raised its price target to US$434.00 from US$300.00.<\/p>\n

Verastem (VSTM)<\/strong> \u2014 Citigroup reiterated its Buy rating.<\/p>\n

Versamet Royalties (VMET)<\/strong> \u2014 TD Securities initiated coverage with a Buy rating.<\/p>\n

Vertex Pharmaceuticals (VRTX)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and raised its price target to US$576.00 from US$570.00.<\/p>\n

Vishay Intertechnology (VSH)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and raised its price target to US$45.00 from US$42.00.<\/p>\n

Vulcan Materials (VMC)<\/strong> \u2014 UBS maintained its Buy rating and lowered its price target to US$326.00 from US$349.00.<\/p>\n

Vylor (VYLR)<\/strong> \u2014 Goldman Sachs initiated coverage with a Buy rating and a US$87.00 price target.<\/p>\n

Wabtec (WAB)<\/strong> \u2014 Citigroup reiterated its Buy rating.<\/p>\n

Warrior Met Coal (HCC)<\/strong> \u2014 UBS maintained its Buy rating and raised its price target to US$102.00 from US$98.00.<\/p>\n

Waste Connections (WCN)<\/strong> \u2014 CIBC set a US$184.00 price target.<\/p>\n

Wayfair (W)<\/strong> \u2014 Baird maintained its Neutral rating and raised its price target to US$117.00 from US$116.00.<\/p>\n

Wells Fargo & Company (WFC)<\/strong> \u2014 TD Cowen resumed coverage with a Buy rating and a US$95.00 price target.<\/p>\n

Werner Enterprises (WERN)<\/strong> \u2014 Stifel maintained its Hold rating and raised its price target to US$42.00 from US$40.00.<\/p>\n

Wheaton Precious Metals (WPM)<\/strong> \u2014 UBS maintained its Buy rating and raised its price target to US$160.00 from US$153.00.<\/p>\n

Workday (WDAY)<\/strong> \u2014 Jefferies reiterated its Hold rating with a US$210.00 price target.<\/p>\n

Xerox (XRX)<\/strong> \u2014 Citigroup downgraded its rating to Sell from Neutral.<\/p>\n

XP (XP)<\/strong> \u2014 UBS maintained its Buy rating and raised its price target to US$37.00 from US$25.00.<\/p>\n

XPO (XPO)<\/strong> \u2014 Stifel maintained its Buy rating and lowered its price target to US$230.00 from US$257.00.<\/p>\n","protected":false},"excerpt":{"rendered":"

Analyst Ratings (USA) Today\u2019s U.S. analyst updates suggest a selectively positive outlook, with greater caution on valuations. Technology and AI-related businesses retain bullish support,…<\/p>\n","protected":false},"author":3,"featured_media":73674,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-76120","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"\nU.S. Analyst Updates: October 8th, 2026 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-8th-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"U.S. Analyst Updates: October 8th, 2026\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings (USA) Today\u2019s U.S. analyst updates suggest a selectively positive outlook, with greater caution on valuations. Technology and AI-related businesses retain bullish support,…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-8th-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-08T20:54:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/05\/Spacexx.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1195\" \/>\n\t<meta property=\"og:image:height\" content=\"474\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"20 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-8th-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-8th-2026\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"U.S. Analyst Updates: October 8th, 2026\",\"datePublished\":\"2026-10-08T20:54:41+00:00\",\"dateModified\":\"2026-10-08T20:54:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-8th-2026\/\"},\"wordCount\":4572,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News & Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-8th-2026\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-8th-2026\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-8th-2026\/\",\"name\":\"U.S. Analyst Updates: October 8th, 2026 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-10-08T20:54:41+00:00\",\"dateModified\":\"2026-10-08T20:54:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-8th-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-8th-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-8th-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"U.S. Analyst Updates: October 8th, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"U.S. Analyst Updates: October 8th, 2026 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-8th-2026\/","og_locale":"en_US","og_type":"article","og_title":"U.S. Analyst Updates: October 8th, 2026","og_description":"Analyst Ratings (USA) Today\u2019s U.S. analyst updates suggest a selectively positive outlook, with greater caution on valuations. Technology and AI-related businesses retain bullish support,…","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-8th-2026\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-10-08T20:54:41+00:00","og_image":[{"width":1195,"height":474,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/05\/Spacexx.jpg","type":"image\/jpeg"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"20 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-8th-2026\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-8th-2026\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"U.S. Analyst Updates: October 8th, 2026","datePublished":"2026-10-08T20:54:41+00:00","dateModified":"2026-10-08T20:54:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-8th-2026\/"},"wordCount":4572,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News & Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-8th-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-8th-2026\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-8th-2026\/","name":"U.S. Analyst Updates: October 8th, 2026 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-10-08T20:54:41+00:00","dateModified":"2026-10-08T20:54:41+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-8th-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-8th-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-8th-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"U.S. Analyst Updates: October 8th, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76120","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=76120"}],"version-history":[{"count":4,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76120\/revisions"}],"predecessor-version":[{"id":76125,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76120\/revisions\/76125"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/73674"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=76120"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=76120"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=76120"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}